Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Since nutrition might have a significant impact on liver function, we analyzed the early effect of Western-type diet on hepatic tissue and lipid and drug metabolism in Wistar–Kyoto rats (n = 8); eight rats fed with a standard diet were used as controls. Histological analysis of liver tissue was performed, and plasma biochemical parameters were measured. Plasma concentration of six bile acids was determined by ultra-liquid chromatography-tandem mass spectrometry UHPLC-MS/MS. Hepatic gene expressions of enzymes involved in drug and lipid metabolism were assessed by means of real-time reverse transcription (qRT)-PCR. Liver of rats fed with a Western diet did not show macroscopic histological alterations, but number and diameter of lipid droplets increased, as well as DGAT1, GPAT4, SCD, FASN and SREBP2 expression. Furthermore, Western diet-fed animals showed an increase in the activation of hepatic stellate cells and macrophage number in liver tissue, as well as a significant increase in AST and bilirubin levels (p < 0.01), and in the LDL:HDL cholesterol ratio (p < 0.001). Plasma chenodeoxycholic acid concentration increased significantly, whereas cholic acid decreased (p < 0.05), and cytochrome P450 genes were generally downregulated. Significant changes in hepatic lipid and drug metabolism are early induced by the Western diet, prior to steatosis development. Such changes are associated with a peculiar alteration in circulating bile acids, which could represent an early marker of non-alcoholic fatty liver disease (NAFLD) development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · cited 15×
“Interestingly, although the histology evidenced the absence of macroscopic alterations, the increases of α-SMA- and CD68-positive cells in the liver, although limited, indicate that a mild activation of HSCs (also confirmed by the increase of α-SMA and Col1A1 mRNA expression in liver tissue, and consistent to what has…”
BackgroundInfluentialFructose, weight gain, and the insulin resistance syndrome,,
Elliott, S. S., Keim, N. L., Stern, J. S., Teff, K., & Havel, P. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.911 · Cited by 1,039
Type 2 diabetes across generations: from pathophysiology to prevention and management
Nolan, C. J., Damm, P., & Prentki, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60614-4 · Cited by 923 · cited 2×
“The lack of physical activity [1], perinatal environment [1,2], and these diets are recognized as obesogenic [1], together with the presence of a predisposing genetic background [3].”
BackgroundRoles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829 · cited 6×
“Interestingly, although the histology evidenced the absence of macroscopic alterations, the increases of α-SMA- and CD68-positive cells in the liver, although limited, indicate that a mild activation of HSCs (also confirmed by the increase of α-SMA and Col1A1 mRNA expression in liver tissue, and consistent to what has…”
BackgroundInfluentialBile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.28709 · Cited by 634 · cited 8×
“Interestingly, although the histology evidenced the absence of macroscopic alterations, the increases of α-SMA- and CD68-positive cells in the liver, although limited, indicate that a mild activation of HSCs (also confirmed by the increase of α-SMA and Col1A1 mRNA expression in liver tissue, and consistent to what has…”
BackgroundInfluentialJu, C., & Tacke, F. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.104 · Cited by 554 · cited 1×
“CD68 is an indicator but not an exclusive marker of Kupffer cells, because also monocyte-derived macrophages infiltrating the liver may express this antigen, and preclinical and clinical studies provide convincing evidence for the pivotal role of macrophages in the development and progression of NAFLD [34] as shown in…”
BackgroundDietary glycemic index and obesity
Ludwig, D. S. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.280s · Cited by 521
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
Mouzaki, M., Wang, A. Y., Bandsma, R., Comelli, E. M., Arendt, B. M., Zhang, L., Fung, S., Fischer, S. E., McGilvray, I. G., & Allard, J. P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151829 · Cited by 385 · cited 6×
“Interestingly, although the histology evidenced the absence of macroscopic alterations, the increases of α-SMA- and CD68-positive cells in the liver, although limited, indicate that a mild activation of HSCs (also confirmed by the increase of α-SMA and Col1A1 mRNA expression in liver tissue, and consistent to what has…”
BackgroundInfluentialAnimal models of non‐alcoholic fatty liver disease: current perspectives and recent advances
Lau, J. K. C., Zhang, X., & Yu, J. (2017) · The Journal of Pathology · doi:10.1002/path.4829 · Cited by 373 · cited 1×
“, [40] and refs therein) leads to the development of NAFLD, a liver disease associated with a Western diet and lifestyle.”
Background
Cited by
Risk assessment with gut microbiome and metabolite markers in NAFLD development
Leung, H., Long, X., Ni, Y., Qian, L., Nychas, E., Siliceo, S. L., Pohl, D., Hanhineva, K., Liu, Y., Xu, A., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abk0855 · Cited by 152
“Cholic acid is a primary bile acid that decreases substantially in rats on a Western diet and is proposed as an early marker of NAFLD development (51).”
BackgroundDepression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH
Colognesi, M., Gabbia, D., & De Martin, S. (2020) · Biomedicines · doi:10.3390/biomedicines8070229 · Cited by 98
Self-citationEffects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis
Tang, Y., Huang, J., Zhang, W. Y., Qin, S., Yang, Y. X., Ren, H., Yang, Q.-B., & Hu, H. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819878046 · Cited by 85
“52 RCT-DB 16 Streptococcus, Bifidobacterium, Lactobacillus Italy 11 (10,12); 10 (9,12) 10 (12); 14 (8) 22 (22) DFI, BMI, TG, ALT, HOMA-IR”
Comeglio, P., Sarchielli, E., Filippi, S., Cellai, I., Guarnieri, G., Morelli, A., Rastrelli, G., Maseroli, E., Cipriani, S., Mello, T., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01522-7 · Cited by 7
Metadata
- Authors
- Gabbia, D., Roverso, M., Guido, M., Sacchi, D., Scaffidi, M., Carrara, M., Orso, G., Russo, F. P., Floreani, A., Bogialli, S., & De Martin, S.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-07-15
- Volume
- 11
- Issue
- 7
- Pages
- 1602
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2956746119
- Cited by
- 42
- References
- 13
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.